Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2606 | 3592 | 38.3 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
304 | 3 | P53//RETINOBLASTOMA//MDM2 | 40663 |
2606 | 2 | FHIT//WWOX//FRAGILE SITES | 3592 |
6494 | 1 | FHIT//WWOX//FRAGILE SITES | 1477 |
12433 | 1 | EI24//CLIN BREAST CARE PROJECT//LOSS OF HETEROZYGOSITY | 906 |
13026 | 1 | NKX31//LZTS1//HOMEOBOX GENE NKX31 | 865 |
33476 | 1 | HBP1//ST7//TESTIS DERIVED TRANSCRIPT | 124 |
34385 | 1 | TPD52//TUMOR PROTEIN D52//MIR 139 5P | 112 |
34666 | 1 | ZNF703//C8ORF4//THYROID CANCER 1 | 108 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FHIT | authKW | 1046209 | 5% | 73% | 169 |
2 | WWOX | authKW | 720229 | 3% | 85% | 100 |
3 | FRAGILE SITES | authKW | 437599 | 3% | 50% | 103 |
4 | FHIT GENE | authKW | 236607 | 1% | 80% | 35 |
5 | COMMON FRAGILE SITES | authKW | 215228 | 1% | 77% | 33 |
6 | FRAGILE HISTIDINE TRIAD | authKW | 201909 | 1% | 85% | 28 |
7 | WW DOMAIN CONTAINING OXIDOREDUCTASE | authKW | 172918 | 1% | 88% | 23 |
8 | TPD52 | authKW | 119718 | 1% | 78% | 18 |
9 | NKX31 | authKW | 113827 | 1% | 56% | 24 |
10 | WOX1 | authKW | 112484 | 0% | 88% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 37664 | 53% | 0% | 1895 |
2 | Genetics & Heredity | 21475 | 33% | 0% | 1169 |
3 | Cell Biology | 2139 | 14% | 0% | 509 |
4 | Pathology | 1679 | 7% | 0% | 242 |
5 | Urology & Nephrology | 816 | 5% | 0% | 184 |
6 | Biochemistry & Molecular Biology | 702 | 16% | 0% | 571 |
7 | Medicine, Research & Experimental | 121 | 3% | 0% | 122 |
8 | Biotechnology & Applied Microbiology | 96 | 4% | 0% | 135 |
9 | Endocrinology & Metabolism | 41 | 3% | 0% | 95 |
10 | Medical Laboratory Technology | 35 | 1% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOL CANC IMRIC | 46270 | 0% | 78% | 7 |
2 | LAUTENBERG IMMUNOL CANC | 31900 | 0% | 29% | 13 |
3 | CLIN BREAST CARE PROJECT | 30620 | 0% | 23% | 16 |
4 | AL QUDS BARD HONORS | 27195 | 0% | 80% | 4 |
5 | KIMMEL CANC | 26790 | 3% | 3% | 91 |
6 | TTUHSC CANC | 25497 | 0% | 100% | 3 |
7 | OSPED SANTO ANDREA | 23529 | 0% | 46% | 6 |
8 | MOL VIROL IMMUNOL MED GENET | 19261 | 2% | 4% | 61 |
9 | HARMON THER EUT ONCOL | 16998 | 0% | 100% | 2 |
10 | IPHB MED BIOCHEM | 16998 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENES CHROMOSOMES & CANCER | 106137 | 6% | 6% | 199 |
2 | CANCER GENETICS AND CYTOGENETICS | 77506 | 7% | 4% | 236 |
3 | CANCER RESEARCH | 13902 | 7% | 1% | 255 |
4 | PROSTATE | 10413 | 2% | 2% | 75 |
5 | HUMAN GENETICS | 8512 | 3% | 1% | 90 |
6 | ONCOGENE | 5034 | 3% | 1% | 105 |
7 | INTERNATIONAL JOURNAL OF ONCOLOGY | 3782 | 2% | 1% | 66 |
8 | CYTOGENETICS AND CELL GENETICS | 3565 | 1% | 1% | 38 |
9 | INTERNATIONAL JOURNAL OF CANCER | 3426 | 3% | 0% | 92 |
10 | GENOMICS | 3017 | 2% | 1% | 55 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FHIT | 1046209 | 5% | 73% | 169 | Search FHIT | Search FHIT |
2 | WWOX | 720229 | 3% | 85% | 100 | Search WWOX | Search WWOX |
3 | FRAGILE SITES | 437599 | 3% | 50% | 103 | Search FRAGILE+SITES | Search FRAGILE+SITES |
4 | FHIT GENE | 236607 | 1% | 80% | 35 | Search FHIT+GENE | Search FHIT+GENE |
5 | COMMON FRAGILE SITES | 215228 | 1% | 77% | 33 | Search COMMON+FRAGILE+SITES | Search COMMON+FRAGILE+SITES |
6 | FRAGILE HISTIDINE TRIAD | 201909 | 1% | 85% | 28 | Search FRAGILE+HISTIDINE+TRIAD | Search FRAGILE+HISTIDINE+TRIAD |
7 | WW DOMAIN CONTAINING OXIDOREDUCTASE | 172918 | 1% | 88% | 23 | Search WW+DOMAIN+CONTAINING+OXIDOREDUCTASE | Search WW+DOMAIN+CONTAINING+OXIDOREDUCTASE |
8 | TPD52 | 119718 | 1% | 78% | 18 | Search TPD52 | Search TPD52 |
9 | NKX31 | 113827 | 1% | 56% | 24 | Search NKX31 | Search NKX31 |
10 | WOX1 | 112484 | 0% | 88% | 15 | Search WOX1 | Search WOX1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HASSAN, MI , NAIYER, A , AHMAD, F , (2010) FRAGILE HISTIDINE TRIAD PROTEIN: STRUCTURE, FUNCTION, AND ITS ASSOCIATION WITH TUMOROGENESIS.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. VOL. 136. ISSUE 3. P. 333 -350 | 117 | 75% | 14 |
2 | SCHROCK, MS , HUEBNER, K , (2015) WWOX: A FRAGILE TUMOR SUPPRESSOR.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 240. ISSUE 3. P. 296 -304 | 82 | 93% | 3 |
3 | DONG, JT , (2001) CHROMOSOMAL DELETIONS AND TUMOR SUPPRESSOR GENES IN PROSTATE CANCER.CANCER AND METASTASIS REVIEWS. VOL. 20. ISSUE 3-4. P. 173 -193 | 136 | 67% | 138 |
4 | GARDENSWARTZ, A , AQEILAN, RI , (2014) WW DOMAIN-CONTAINING OXIDOREDUCTASE'S ROLE IN MYRIAD CANCERS: CLINICAL SIGNIFICANCE AND FUTURE IMPLICATIONS.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 239. ISSUE 3. P. 253 -263 | 73 | 80% | 20 |
5 | DURKIN, SG , GLOVER, TW , (2007) CHROMOSOME FRAGILE SITES.ANNUAL REVIEW OF GENETICS. VOL. 41. ISSUE . P. 169-192 | 83 | 61% | 318 |
6 | SAVELYEVA, L , BRUECKNER, LM , (2014) MOLECULAR CHARACTERIZATION OF COMMON FRAGILE SITES AS A STRATEGY TO DISCOVER CANCER SUSCEPTIBILITY GENES.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 71. ISSUE 23. P. 4561 -4575 | 84 | 75% | 5 |
7 | MA, K , QIU, L , MRASEK, K , ZHANG, J , LIEHR, T , QUINTANA, LG , LI, Z , (2012) COMMON FRAGILE SITES: GENOMIC HOTSPOTS OF DNA DAMAGE AND CARCINOGENESIS.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 13. ISSUE 9. P. 11974-11999 | 94 | 64% | 16 |
8 | O'KEEFE, LV , RICHARDS, RI , (2006) COMMON CHROMOSOMAL FRAGILE SITES AND CANCER: FOCUS ON FRA16D.CANCER LETTERS. VOL. 232. ISSUE 1. P. 37-47 | 77 | 81% | 53 |
9 | ABU-REMAILEH, M , JOY-DODSON, E , SCHUELER-FURMAN, O , AQEILAN, RI , (2015) PLEIOTROPIC FUNCTIONS OF TUMOR SUPPRESSOR WWOX IN NORMAL AND CANCER CELLS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 290. ISSUE 52. P. 30728 -30735 | 61 | 80% | 4 |
10 | GAO, G , SMITH, DI , (2015) WWOX, LARGE COMMON FRAGILE SITE GENES, AND CANCER.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 240. ISSUE 3. P. 285 -295 | 71 | 72% | 1 |
Classes with closest relation at Level 2 |